600479.SS
Strong BuyFull HouseAI concernZhuZhou QianJin Pharmaceutical Co.,Ltd · Healthcare · China · $909M
CNY 12.40 +3.8% · close 30 Sep · scored 7 Oct
Full House: Strong business, sensible price, market agrees. The rare full house.
Strong on the numbers, but the AI review named a specific concern. Its reason is in the AI review below.
Does StockRank work? Each month we publish how every decile did, whichever way it went. See the record →
Generic healthcare thesis with insufficient differentiation to justify high-conviction status in a concentrated global equity portfolio.
ABOUT ZHUZHOU QIANJIN PHARMACEUTICAL CO.,LTD
Read
ZhuZhou QianJin Pharmaceutical Co.,Ltd researches, develops, produces, and sells traditional Chinese medicines, chemicals and API, and TCM derivatives in China.
FINANCIAL SUMMARY (CNY)
| Year | 2022 | 2023 | 2024 | 2025 | CAGR | TTM |
|---|---|---|---|---|---|---|
| Revenue | 4.0B | 3.8B | 3.6B | 3.6B | -3.4% | 3.7B |
| EPS (CNY) | 0.71 | 0.76 | 0.56 | 0.66 | -2.0% | 0.73 |
| Shares | 429.8M | 428.9M | 424.0M | 492.2M | +14.5% | 492.2M |
| Debt | 124.2M | 116.7M | 58.6M | 101.5M | -6.5% | 155.7M |
| Equity | 2.2B | 2.4B | 2.5B | 3.0B | 11.0% | — |
| Op CF | 733.5M | 443.1M | 398.8M | 480.2M | -13.2% | 576.7M |
| Inv CF | 122.1M | 585.3M | -741.2M | -931.0M | — | — |
| Fin CF | -264.2M | -202.0M | -250.1M | -149.0M | — | — |
Calmer than 53% of stocks we rank over the past year (40% a year).
How this is worked out
What it measures: day-to-day price moves over the past year, as a yearly figure, ranked against every stock we cover. Very calm under 20% a year, Calm 20 to 30%, Average 30 to 40%, Bumpy 40 to 55%, Very bumpy above that.
What we found: across about 13,500 stocks in 34 markets (2002 to 2025), past swings were a good guide to the next year's, and bumpier stocks fell further. How much further changed too much between eras to put a number on it.
Calm is not safe: a calm stock can still slide steadily.
Rules fixed before any data was fetched. Describes the chart, not a recommendation.
SCORE BREAKDOWN
FUNDAMENTALS
SECTOR PEERS
Closest peers in Healthcare, ranked by industry match, size, and score similarity. Cross-listings of 600479.SS are excluded.
| Ticker | Company | Mkt Cap | StockRank | Signal |
|---|---|---|---|---|
| 600479.SS | ZhuZhou QianJin Pharmaceutical Co.,Ltd(you) | $909M | 93 | Strong Buy |
| 000650.SZ | Renhe Pharmacy Co.,Ltd | $1.1B | 95 | Strong Buy |
| 000915.SZ | Shandong Wit Dyne Health Co.,Ltd. | $837M | 98 | Strong Buy |
| 002275.SZ | Guilin Sanjin Pharmaceutical Co., Ltd. | $1.1B | 89 | Strong Buy |
| 603367.SS | Cisen Pharmaceutical Co., Ltd. | $963M | 87 | Strong Buy |
| 000989.SZ | Jiuzhitang Co., Ltd. | $1.1B | 89 | Strong Buy |
| 2877.HK | China Shineway Pharmaceutical Group Limited | $791M | 99 | Strong Buy |
| 9989.HK | Shenzhen Hepalink Pharmaceutical Group Co., Ltd. | $732M | 86 | Strong Buy |
| 600351.SS | Yabao Pharmaceutical Group Co., Ltd | $687M | 99 | Strong Buy |
| 002332.SZ | Zhejiang Xianju Pharmaceutical Co., Ltd. | $1.3B | 87 | Strong Buy |
Peer medians: ROE 4.3% · P/E 27.8x · Gross margin 53.0%
Company Deep Dive
Business segments breakdown, earnings transcript analysis, management credibility scoring, competitive landscape, and scenario modelling.